Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
Othman A. Al‐Shabanah(King Saud University), Abdullah M. Al‐Bekairi, Osama A. Badary(Ain Shams University), N.M. Al-Gharably, Mahmoud N. Nagi(King Saud University), Ammar C. Al‐Rikabi(King Saud University)
PubMed
June 1, 1998
Cited by 149
Related Papers
Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity
|Canadian Journal of Physiology and Pharmacology|1997|222
Thymoquinone protects against carbon tetrachloride hetatotoxicity in mice via an antioxidant mechanism
|IUBMB Life|1999|195
Thymoquinone Attenuates Diethylnitrosamine Induction of Hepatic Carcinogenesis Through Antioxidant Signaling
|Oxidative Medicine and Cellular Longevity|2010|167
Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism
|Molecular Neurobiology|2016|166